venkata sita rama raju allam

About

Passionate researcher with a strong background in pharmacology and immunology and having 5+ years of working experience in both academic and pharmaceutical industry based research. Well-versed in setting and validating different in vitro, in vivo and ex vivo assays to investigate and delineate the novel therapeutic targets for the treatment of respiratory, inflammatory and autoimmune diseases

Employment

• Woolcock Institute of Medical Research Postdoctoral Research Scientist
  2019 - 2020
• Uppsala universitet Uppsala biomedicinska centrum Postdoctoral

Education

• University of Technology Sydney PHD
  2014 - 2019

Projects & Funding

Projects & funding information is unavailable.

Publications (29)

• Disruption of the mast cell carboxypeptidase A3 gene does not attenuate airway inflammation and hyperresponsiveness in two mouse models of asthma
  PLoS ONE 2024 DOI: 10.1371/journal.pone.0300668
  +Save
• Exploring the role of the ocular surface in the lung-eye axis: Insights into respiratory disease pathogenesis
  Venkata Sita Rama Raju Allam, Vyoma K. Patel, Gabriele De Rubis +7 more
  Life Sciences 2024 DOI: 10.1016/j.lfs.2024.122730
  +Save
• Involvement of osteopontin, EpCAM, estrogen receptor-alpha, and carbonic anhydrase IX protein in managing lung cancer via Berberine-loaded liquid crystalline nanoparticles
  Gabriele De Rubis, Keshav Raj Paudel, Venkata Sita Rama Raju Allam +8 more
  Pathology Research and Practice 2024 DOI: 10.1016/j.prp.2023.154971
  +Save
• Monensin Suppresses Multiple Features of House Dust Mite-Induced Experimental Asthma in Mice
  Inflammation 2024 DOI: 10.1007/s10753-024-02090-7
  +Save
• Non-coding RNA: A key regulator in the Glutathione-GPX4 pathway of ferroptosis
  Md Sadique Hussain, Gaurav Gupta, Moyad Jamal Shahwan +11 more
  Non-coding RNA Research 2024 DOI: 10.1016/j.ncrna.2024.05.007
  +Save
• Nafamostat has anti-asthmatic effects associated with suppressed pro-inflammatory gene expression, eosinophil infiltration and airway hyperreactivity.
  Frontiers in immunology 2023 DOI: 10.3389/fimmu.2023.1136780
  +Save
• Tackling the cytokine storm using advanced drug delivery in allergic airway disease
  Vyoma K. Patel, Sukriti Vishwas, Rajan Kumar +14 more
  Journal of Drug Delivery Science and Technology 2023 DOI: 10.1016/j.jddst.2023.104366
  +Save
• In vitro anti-cancer activity of a polyherbal preparation, VEDICINALS®9, against A549 human lung adenocarcinoma cells
  Keshav Raj Paudel, Rashi Rajput, Gabriele De Rubis +8 more
  Pathology Research and Practice 2023 DOI: 10.1016/j.prp.2023.154832
  +Save
• Macrophage migration inhibitory factor promotes glucocorticoid resistance of neutrophilic inflammation in a murine model of severe asthma
  Thorax 2022 DOI: 10.1136/thorax-2021-218555
  +Save
• An Introduction to Respiratory Diseases and an Emerging Need for Efficient Drug Delivery Systems
  Krishna Sunkara, Meenu Mehta, Saurabh Satija +7 more
  Advanced Drug Delivery Strategies for Targeting Chronic Inflammatory Lung Diseases 2022 DOI: 10.1007/978-981-16-4392-7_1
  +Save
• Nutraceuticals and mitochondrial oxidative stress: bridging the gap in the management of bronchial asthma
  Venkata Sita Rama Raju Allam, Keshav Raj Paudel, Gaurav Gupta +14 more
  Environmental Science and Pollution Research 2022 DOI: 10.1007/s11356-022-21454-w
  +Save
• Recent Advances in Chronotherapy Targeting Respiratory Diseases.
  Keshav Raj Paudel, Saurav Kumar Jha, Venkata Sita Rama Raju Allam +13 more
  Pharmaceutics 2021 DOI: 10.3390/pharmaceutics13122008
  +Save
• Nutraceuticals: unlocking newer paradigms in the mitigation of inflammatory lung diseases.
  Yinghan Chan, Venkata Sita Rama Raju Allam, Keshav Raj Paudel +11 more
  Critical reviews in food science and nutrition 2021 DOI: 10.1080/10408398.2021.1986467
  +Save
• LL-37 and HMGB1 induce alveolar damage and reduce lung tissue regeneration via RAGE.
  American journal of physiology. Lung cellular and molecular physiology 2021 DOI: 10.1152/ajplung.00138.2021
  +Save
• Recent trends of NFκB decoy oligodeoxynucleotide-based nanotherapeutics in lung diseases.
  Meenu Mehta, Keshav Raj Paudel, Shakti Dhar Shukla +16 more
  Journal of controlled release : official journal of the Controlled Release Society 2021 DOI: 10.1016/j.jconrel.2021.08.010
  +Save
• Interleukin-13: A pivotal target against influenza-induced exacerbation of chronic lung diseases.
  Madhur D. Shastri, Venkata Sita Rama Raju Allam, Shakti Dhar Shukla +7 more
  Life sciences 2021 DOI: 10.1016/j.lfs.2021.119871
  +Save
• Nuclear factor-kappa B and its role in inflammatory lung disease.
  Khalid Saad Alharbi, Neeraj Kumar Fuloria, Shivkanya Fuloria +10 more
  Chemico-biological interactions 2021 DOI: 10.1016/j.cbi.2021.109568
  +Save
• Treatment of chronic airway diseases using nutraceuticals: Mechanistic insight.
  Venkata Sita Rama Raju Allam, Dinesh Kumar Chellappan, Niraj Kumar Jha +13 more
  Critical reviews in food science and nutrition 2021 DOI: 10.1080/10408398.2021.1915744
  +Save
• The FBXW7-NOTCH interactome: A ubiquitin proteasomal system-induced crosstalk modulating oncogenic transformation in human tissues.
  Rohan Kar, Saurabh Kumar Jha, Shreesh Kumar Ojha +14 more
  Cancer reports (Hoboken, N.J.) 2021 DOI: 10.1002/cnr2.1369
  +Save
• Letter to the editor: Covid-19 in underlying copd patients
  Krishna Sunkara, Venkata Sita Rama Raju Allam, Shakti Dhar Shukla +4 more
  EXCLI Journal 2021 DOI: 10.17179/excli2021-3322
  +Save